These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3120775

  • 1. Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin.
    Soeda S, Kakiki M, Shimeno H, Nagamatsu A.
    Biochim Biophys Acta; 1987 Dec 18; 916(3):279-87. PubMed ID: 3120775
    [Abstract] [Full Text] [Related]

  • 2. Localization of the binding site of tissue-type plasminogen activator to fibrin.
    Ichinose A, Takio K, Fujikawa K.
    J Clin Invest; 1986 Jul 18; 78(1):163-9. PubMed ID: 3088041
    [Abstract] [Full Text] [Related]

  • 3. Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments.
    de Munk GA, Caspers MP, Chang GT, Pouwels PH, Enger-Valk BE, Verheijen JH.
    Biochemistry; 1989 Sep 05; 28(18):7318-25. PubMed ID: 2510823
    [Abstract] [Full Text] [Related]

  • 4. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator.
    Bakker AH, Rehberg EF, Marotti KR, Verheijen JH.
    Protein Eng; 1995 Mar 05; 8(3):293-300. PubMed ID: 7479691
    [Abstract] [Full Text] [Related]

  • 5. Further characterization of the binding of plasminogen to heparin: evidence for the involvement of lysine residues.
    Soeda S, Ohki H, Shimeno H, Nagamatsu A.
    Biochim Biophys Acta; 1989 Nov 09; 999(1):29-35. PubMed ID: 2572276
    [Abstract] [Full Text] [Related]

  • 6. A covalent molecular weight approximately 92,000 hybrid plasminogen activator derived from human plasmin fibrin-binding and tissue plasminogen activator catalytic domains.
    Robbins KC, Boreisha IG.
    Biochemistry; 1987 Jul 28; 26(15):4661-7. PubMed ID: 3117104
    [Abstract] [Full Text] [Related]

  • 7. Effects of monoclonal antibodies on tissue-type plasminogen activator (t-PA) binding to lysine, fibrin and heparin and on fibrin-mediated enhancement of one-chain t-PA amidolytic activity.
    Fischer B, Zacharias U, Will H.
    Biol Chem Hoppe Seyler; 1991 Apr 28; 372(4):263-71. PubMed ID: 1905550
    [Abstract] [Full Text] [Related]

  • 8. Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.
    Andrade-Gordon P, Strickland S.
    Proc Natl Acad Sci U S A; 1990 Mar 28; 87(5):1865-9. PubMed ID: 2106684
    [Abstract] [Full Text] [Related]

  • 9. Initial interaction between fibrin and tissue plasminogen activator (t-PA). The Gly-Pro-Arg-Pro binding site on fibrin(ogen) is important for t-PA activity.
    Kaczmarek E, Lee MH, McDonagh J.
    J Biol Chem; 1993 Feb 05; 268(4):2474-9. PubMed ID: 8428923
    [Abstract] [Full Text] [Related]

  • 10. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.
    van Zonneveld AJ, Veerman H, Pannekoek H.
    J Biol Chem; 1986 Oct 25; 261(30):14214-8. PubMed ID: 3021732
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quantitative analysis of fibrin-binding affinity of fibrinolytic components by frontal affinity chromatography.
    Kazama M, Tahara C, Abe T, Kasai K.
    Thromb Res Suppl; 1988 Oct 25; 8():81-90. PubMed ID: 3144771
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Binding of one-chain tissue-type plasminogen activator to fibrin, partially plasmin-degraded fibrin, lysine and heparin.
    Fischer B.
    Biomed Biochim Acta; 1991 Oct 25; 50(1):47-54. PubMed ID: 1830477
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A, Castellino FJ.
    Arch Biochem Biophys; 1993 Jan 25; 300(1):472-82. PubMed ID: 8424682
    [Abstract] [Full Text] [Related]

  • 18. Modulation of tissue plasminogen activator-catalyzed plasminogen activation by synthetic peptides derived from the amino-terminal heparin binding domain of fibronectin.
    Stack MS, Pizzo SV.
    J Biol Chem; 1993 Sep 05; 268(25):18924-8. PubMed ID: 8360182
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.